These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17345122)

  • 41. The significance of lower extremity peripheral arterial disease.
    Dieter RS; Chu WW; Pacanowski JP; McBride PE; Tanke TE
    Clin Cardiol; 2002 Jan; 25(1):3-10. PubMed ID: 11808837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interventional strategies in early atherosclerosis.
    Gattone M; Giannuzzi P
    Monaldi Arch Chest Dis; 2006 Mar; 66(1):54-62. PubMed ID: 17125046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous vascular interventions in the superficial femoral artery. A review.
    Wiesinger B; Heller S; Schmehl J; Claussen CD; Wiskirchen J; Tepe G
    Minerva Cardioangiol; 2006 Feb; 54(1):83-93. PubMed ID: 16467744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essentials in the diagnosis and management of peripheral arterial disease.
    Medina-Ruiz A; Sánchez-Vélez ME
    P R Health Sci J; 2004 Dec; 23(4):313-8. PubMed ID: 15776695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chapter III: Management of cardiovascular risk factors and medical therapy.
    Diehm N; Schmidli J; Setacci C; Ricco JB; de Donato G; Becker F; Robert-Ebadi H; Cao P; Eckstein HH; De Rango P; Teraa M; Moll FL; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S33-42. PubMed ID: 22172471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral arterial disease: medical care and prevention of complications.
    Dawson DL; Hiatt WR; Creager M; Hirsch AT
    Prev Cardiol; 2002; 5(3):119-30. PubMed ID: 12091754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral arterial disease in the elderly: recognition and management.
    Aronow H
    Am J Cardiovasc Drugs; 2008; 8(6):353-64. PubMed ID: 19159122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical treatment of peripheral arterial disease.
    Hankey GJ; Norman PE; Eikelboom JW
    JAMA; 2006 Feb; 295(5):547-53. PubMed ID: 16449620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Choosing the right medication for the right patient].
    Durand E; Kadri Z; Danchin N
    Rev Prat; 2005 Oct; 55(16):1805-11. PubMed ID: 16363431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical treatment of peripheral artery occlusive disease (PAOD).
    Clement DL
    Acta Chir Belg; 2000; 100(5):190-3. PubMed ID: 11143319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral arterial disease: insights from population studies of older adults.
    Newman AB
    J Am Geriatr Soc; 2000 Sep; 48(9):1157-62. PubMed ID: 10983919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease.
    Hirsch AT; Duprez D
    Vasc Med; 2003 Nov; 8(4):273-8. PubMed ID: 15125489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Peripheral arterial disease: where are we in 2006?].
    Sraieb T; Bougamra S; Ben Romdhane N; Longo S; Manaa J
    Tunis Med; 2007 May; 85(5):361-6. PubMed ID: 17657918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endovascular treatment of peripheral arterial disease.
    Gray BH
    J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 2):S15-20. PubMed ID: 11105463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease.
    Ix JH; Criqui MH
    Adv Chronic Kidney Dis; 2008 Oct; 15(4):378-83. PubMed ID: 18805384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral arterial disease: considerations in risks, diagnosis, and treatment.
    Mukherjee D; Cho L
    J Natl Med Assoc; 2009 Oct; 101(10):999-1008. PubMed ID: 19860299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location.
    Barretto S; Ballman KV; Rooke TW; Kullo IJ
    Vasc Med; 2003 May; 8(2):95-100. PubMed ID: 14518611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacotherapy and behavioral intervention for peripheral arterial disease.
    Doyle J; Creager MA
    Rev Cardiovasc Med; 2003; 4(1):18-24. PubMed ID: 12684600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.